Avidity Partners Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-175,000
Closed -$15.7M 130
2021
Q2
$15.7M Buy
+175,000
New +$14.8M 0.42% 59
2020
Q3
Sell
-366,500
Closed -$21.3M 91
2020
Q2
$21.3M Buy
+366,500
New +$19.7M 1.37% 26

Other funds holding SYNH

Avidity Partners Management's SYNH Position: Q3 2021 in Review

Avidity Partners Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2021, closing a stake of 175,000 shares — an estimated $15.7M sold.

Avidity Partners Management first reported a position in SYNH in Q2 2020 and held it in 2 quarters. The position peaked at $21.3M in Q2 2020. 355 funds tracked by Wall St. Rank hold SYNH as of Q3 2021.

  • Avidity Partners Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2021 after selling out during the quarter.
  • Avidity Partners Management sold 175,000 Syneos Health, Inc. Class A Common Stock shares in Q3 2021, an estimated $15.7M.
  • Avidity Partners Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2020 and held it in 2 quarters.
  • Avidity Partners Management's Syneos Health, Inc. Class A Common Stock position peaked at $21.3M in Q2 2020.
  • 355 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2021.

Based on Avidity Partners Management's 13F filing for Q3 2021, filed 15 Nov 2021.